Journal:Cancer

Co-author:Li Yuanjian, Ma Jinan, Peng Liubao, Wan Xiaomin

Volume:123

Issue:14

Page Number:2634-2641

Translation or Not:no

Next One:First-Line Atezolizumab in Addition to Bevacizumab Plus Chemotherapy for Metastatic, Nonsquamous Non–Small Cell Lung Cancer: A United States–Based Cost-Effectiveness Analysis